Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of EDP1815 in mild to moderate plaque psoriasis
2019-004901-28Phase 2Unknown
- Sponsor
- Evelo Biosciences
- Start
- Feb 2020
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of EDP1815 in psoriasis (4 arms), sponsored by Evelo Biosciences. Status: unknown.
02
Drugs
EDP1815
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2019-004901-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004901-28.